Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies. Methods We conducted a multicenter, nested case-control study of Alzheimer's disease biomarkers in cognitively normal participants who were enrolled in the China Cognition and Aging Study from January 2000 through December 2020. A subgroup of these participants underwent testing of cerebrospinal fluid (CSF), cognitive assessments, and brain imaging at 2-year-to-3-year intervals. A total of 648 participants in whom Alzheimer's disease developed were matched with 648 participants who had normal cognition, and the temporal trajectories of CSF biochemical marker concentrations, cognitive testing, and imaging were analyzed in the two groups. Results The median follow-up was 19.9 years (interquartile range, 19.5 to 20.2). CSF and imaging biomarkers in the Alzheimer's disease group diverged from those in the cognitively normal group at the following estimated number of years before diagnosis: amyloid-beta (Aβ) 42 , 18 years; the ratio of Aβ 42 to Aβ 40 , 14 years; phosphorylated tau 181, 11 years; total tau, 10 years; neurofilament light chain, 9 years; hippocampal volume, 8 years; and cognitive decline, 6 years. As cognitive impairment progressed, the changes in CSF biomarker levels in the Alzheimer's disease group initially accelerated and then slowed. Conclusions In this study involving Chi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study indicated that within 20 years, abnormalities in CSF Aβ42, the ratio of CSF Aβ42 to Aβ40, CSF P-tau181, CSF T-tau, CSF neurofilament light chain (NfL), and hippocampal volume (as detected by sMRI) appear in sequence before the clinical diagnosis of SAD.375”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [375]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Vrieze, S. I. (2012) · Psychological Methods · doi:10.1037/a0027127 · Cited by 1,948
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Cited by
Items 401–488 of 488
Identification of a CD44-dependent control of astrocytic autophagic activity in Alzheimer’s disease
Wang, H., Long, Y., Tang, Y., Duan, L., Wang, Z., Zhang, S., Yin, Y., Zhou, J., Wu, W., & Zhong, C. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100601
High-Accuracy Alzheimer’s Disease Stage Identification from MRI Using EfficientNet Model
Yan, B. (2026) · International Conference on Vision, Advanced Imaging and Computer Technology (VAICT) · doi:10.1109/vaict69205.2026.11519376
Soladoye, A. A., Osborne, A., Ojo, A., Matope, E. M., Bamidele, D. B., & Olawade, D. B. (2026) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2026.05.006
Thalamic nuclei insights into Alzheimer’s diseasePreprint
Vidal, J. P. C., Myall, D. J., Pariente, J., Pitcher, T. L., Roberts, R. P., Cawston, E. E., Heron, C. J. L., Anderson, T., Morgan, C., Melzer, T. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.728015
The physiological effects of APOE genotype in healthy young/middle‐aged individuals
de Leeuw, S. M., Emrani, S., Putter, J., & Nuriel, T. (2026) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1002/brv.70187 · Cited by 1
Trieu, C., Dicks, E., de Leeuw, D. M., de Wit, K. D. M., van Leeuwenstijn, M. S. S. A., Schlüter, L., Boonkamp, L., Barkhof, F., ten Kate, M., van de Giessen, E., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218119
Early Gut Microbiome Alterations in Mild Cognitive Impairment Reflect Changes in Alzheimer Disease
Brandt, E., Koivisto, A., Pereira, P. A. B., Mustanoja, E., Auvinen, P., Saari, T. T., Rusanen, M., Leinonen, V., Scheperjans, F., & Kärkkäinen, V. (2026) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000732
Neue biomarkergestützte Alzheimerbehandlung: Interdisziplinäre Herausforderungen
Goedecke, J., Fink, G. R., & Onur, O. A. (2026) · DNP – Die Neurologie & Psychiatrie · doi:10.1007/s15202-026-6702-3
Peña‐Bautista, C., Garíca-Vallés, L., Álvarez‐Sánchez, L., Ferré‐González, L., Peretó, M., Raga, L., Cháfer‐Pericás, C., & Baquero, M. (2026) · Neurología · doi:10.1016/j.nrl.2026.502095
Protein Dynamics Beyond Structure PredictionPreprint
Griffié, J., Shashkova, S., Ciarlo, A., Manikandan, S. K., Andréasson, C., Bäckström, M., Bereau, T., Brismar, H., Bustamante, C., Carroni, M., et al. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2606.08647
Yu, X., Kong, L., Wang, B., Liu, J., Lv, X., Sun, Q., Liu, R., Zhao, B., Lv, J., & Gao, Y. (2026) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2026.117607
Self-citationPlasma p‐tau markers, vascular factors, and cognitive decline in the CIMA‐Q cohort
Cottez, R. J., Peyrot, C., Denis, H. L., Tremblay, C., Loiselle, A., Dallaire‐Théroux, C., Filali‐Mouhim, A., Hébert, S. S., Leclerc, N. M., Blennow, K., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71588
Li, X., Rockall, A., Edison, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R. C., Jack, C. R., Jagust, W. J., Landau, S. M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-54109-8
Li, N., Jiang, K., Peng, X., Yang, C., Xiong, W., & Wang, W. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1820691
Gong, Y., Qu, M., Xu, Y., Bao, H., Shen, T., Zeng, L., Wu, X., & He, Q. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102333
Exploring Alzheimer Disease from a Retinal and Ocular Perspective
Victoria-Martínez, J., & Martín‐Nieto, J. (2026) · Biomedicines · doi:10.3390/biomedicines14071465
TUBB4B mRNA in CSF and plasma exosomes as a biomarker for tracking Alzheimer's disease progression
Yang, X., Gao, S., & Wang, P. Y. (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102555
Defining and Measuring Cognitive Decline and Clinical Relevance
Kurz, C., NEWHOUSE, P. A., Wyman‐Chick, K. A., Galvin, J. E., Lautenschlager, N. T., & Sabbagh, M. N. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-00996-y
Jordan, D. M., Kritzer, E., Thompson, R. C., Lund, A. N., Patel, T., Grice, A. B., John, D., Initiative, A. D. N., Initiative, A. D. N., Goate, A., et al. (2026) · medRxiv · doi:10.64898/2026.07.07.26356710
Quan, S., Fu, X., Cai, H., Zhang, W., Geng, Y., Tian, Q., Ren, Z., Xu, Y., An, C., Li, J., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00513-5
Brendler, A., Fietz, J., Bauer, A., Pfahl, D., Higgins, S., Vidovič, E., Brueckl, T., BeCOME working group, Hupe, K., Knop, M., et al. (2026) · medRxiv · doi:10.64898/2026.07.15.26358187
Evaluation of distinct and similar pathological features between diabetes and Alzheimer’s disease
Reed, J., Bain, S. C., & Kanamarlapudi, V. (2026) · EXCLI journal · doi:10.17179/excli2026-9429
Lawal, A. O., Jacob, I. B., Karnik, V., Fan, H., Thangamani, S., Massa, P. T., & Wang, G. (2026) · Viruses · doi:10.3390/v18070783
Longitudinal assessment of intraocular pressure in the 5xFAD mouse model of Alzheimer's disease
Rubinshtein, R., Obied, B., Salti, T., König, A. I., Zahavi, A., & Goldenberg‐Cohen, N. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1858031
Encoding Discordance in the Alzheimer’s Disease A/T/N FrameworkPreprint
DeLong, L. N., Salimi, Y., Balabin, H., Galdi, P., Fleuriot, J., Brennan, P. M., & Initiative, A. D. N. (2026) · medRxiv · doi:10.64898/2026.07.19.26358425
Garay-Mayol, B., Navarro‐Orcajada, S., Poveda-Lora, S., Brito, M. A., Giménez‐Bastida, J. A., Ávila‐Gálvez, M. Á., & González‐Sarrías, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146487 · Cited by 1
PAULEY, M. E., Coughlan, C. M., Dong, F., Bucca, B. C., Tanner, B., CHARTIER-LOGAN, C. J., Shapiro, A. L. B., & Snell‐Bergeon, J. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860993
Prädiktion und Prävention der Alzheimer-Krankheit
Weber, M. A., Goedecke, J., Fink, G. R., & Onur, O. A. (2026) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2906-0084
Zhou, Y., Diao, Y., Yan, Z., Shui, X., Huang, Z., Sun, Y., Wang, S. W., Xia, Y., Lee, T. H., & Wang, L. (2026) · Biomolecules · doi:10.3390/biom16081075
Self-citationMetabolomic Profiles and Changes During the 20 Years Preceding Heart Failure
Li, J., Ding, S., Yang, Z., Wang, M., Deng, X., Sun, X., Lu, W., Jia, P., Liu, Y., Zhang, Y., et al. (2026) · Circulation Research · doi:10.1161/circresaha.126.328542
Kuo, Y., Tzeng, H., Shan, Y., Jang, J. H., Cram, P. M., & Raji, M. A. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70599
Zhang, X., Zhuang, D., Lai, C., Zheng, C., Soh, Z. D., Wagner, S. K., Cai, V. Y., Yang, Z., Wang, S., Geng, X., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101504
Self-citationGenetic architecture of Alzheimer’s disease-related plasma biomarkers
Aaltonen, A., Palviainen, T., Heikkinen, S., Herukka, S.-K., Hiltunen, M. O., Kokkola, T., Kärkkäinen, S., FinnGen, Palotie, A. V., Runz, H., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.07.010
Wang, S., Shang, N., Chen, W., Zhang, S., Zhang, J., Meng, H., Guo, X., Pan, B., He, C., Lu, X., et al. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.6c01298
Self-citationStructural changes in gray matter and white matter across the Alzheimer’s disease continuum
Lin, S., Xue, M., Wang, T., Chen, Y., Sheng, C., Sun, J., Sui, Y., Zou, W., Lian, J., Peng, J., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1853132
Pérez, E. Y. J., Ortiz-Escobar, T. B., Bravo, A. J. A., & Villacis, I. C. L. (2026) · Revista Politécnica de la Ciencia · doi:10.56519/40dkrq29
Le concept de sujet à risque dans la maladie d’Alzheimer
Villain, N. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.06.015
Du, X., Zhang, T., Wan, Z., Zhang, W., Yan, B., Zhang, T., Su, Y., Wang, G., Zhang, L., & Luo, H. (2026) · ACS Sensors · doi:10.1021/acssensors.6c02990
Nguyen, H. M., & Nguyen, L. D. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06113-2
Plasma p-tau217 and NfL predict incident dementia in the communityPreprint
Sunde, A. L., Tovar, D., Vik‐Mo, A. O., Zetterberg, H., Arslan, B., Tan, K., Huber, H., Persson, K., Molfetta, G. D., Pola, I., et al. (2026) · medRxiv · doi:10.64898/2026.08.07.26359934
Wu, Y., Xu, Q., Qin, Z.-H., Wu, X., Hu, Z., Yang, W., Ren, P.-Y., Tian, Y.-Y., Lin, Z., & Xian, Y. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01896-5 · Cited by 1
Martins, M. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.230
Xie, B., Zhang, W., Zhang, Y., Liu, L., You, J., & Li, Q. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1852137
Multimodal mechanistic pathways in Alzheimer’s disease: toward an integrated model of pathogenesis
Souza, C. D., Nanjundappa, S. M., & Murali, N. (2026) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20262874
Neurological disease progression in adults with ataxia-telangiectasia: a longitudinal study
Hensiek, A. E., Bottolo, L., Tiet, M. Y., Harrison, E., Ashby, E., Olympio, C., Biggs, H., Everett, N., Schon, K., & Horváth, R. (2026) · Brain · doi:10.1093/brain/awag285
Gao, F., Luo, G., Liu, B., Qiu, X., Bai, J., & Wang, R. (2026) · iScience · doi:10.1016/j.isci.2026.117250
Wu, X., Zhu, Y., Du, S., Chen, Q., Chen, F., Xu, X., Long, C., Ge, D., Lei, Y., Bai, Y., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122183
Self-citationKorni, A., & Zandi, E. (2026) · Journal of Experimental Neurology · doi:10.33696/neurol.7.131 · Cited by 1
Han, J., Fang, Y., Esiaka, D. K., & Abraham, O. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1900651
Alves, D. C. T., Zander, L. R. M., Alves, F. B. T., & de Gomes, M. G. (2026) · Revista Multidisciplinar do Nordeste Mineiro · doi:10.66104/hdwza540
Menezes, J., Barbosa, M. I. A., & Rodrigues, P. M. (2026) · Sensors · doi:10.3390/s26175489
EEG microstate dynamics across sleep stages in Alzheimer’s disease: A pilot study
Hu, G., Tong, Y., Liu, L., Zhang, Y., & Zhang, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112104
Gyebi, G. A., Onesi, O. O., & Sabiu, S. (2026) · Biochemistry Research International · doi:10.1155/bri/4503245
Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practice
Agnello, L., Pilotto, A., Gaetani, L., Bellomo, G., Bessi, V., Bozzali, M., Cagnin, A., Labate, A., Massa, F., Moda, F., et al. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-1113
FDG-PET in Cognitive Impairment and Dementia
Hong, J., & Silverman, D. H. S. (2026) · PET Clinics · doi:10.1016/j.cpet.2026.07.001
Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease
Han, Z., Liu, W., Fu, W., Wang, K., Tan, Z., Zhang, D., Yang, F., Dong, W., & Sang, Z. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179320
Russo, M. J., Bueri, J., Alba-Ferrara, L., Sevlever, G. E., & Allegri, R. (2026) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2026.2732062
Ribeiro, E. A., Antonângelo, L., & Gomes, H. R. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00329-7
Wang, J., Li, Z., Wang, T., Jiang, L., Sharif, A., Takechi, R., Li, T., Chong, L. H., Fang, F., Pang, Z., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.013
Li, Y., Pu, K., Li, D., Zhao, Y., Cai, Q., Zhou, X., Li, S., Chen, Y., Zhou, Z., & Liu, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103376
Self-citationLuo, Y., Chen, L., Yin, S., Zhang, L., Chen, B., & Wen, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261487603
Qin, J., Yu, X., Wang, Y., Song, X., Wang, Y., Wang, Z., Miao, W., Yang, X., Zhu, J., Zhu, X., et al. (2026) · iNew Medicine · doi:10.1002/inm3.70074
Self-citationLi, J., Xiang, X., Long, S., Hu, F., & Ding, F. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1905634
Jagasia, K., & Li, C. (2026) · Applied Neuropsychology Adult · doi:10.1080/23279095.2026.2740096
Minqiang, 康. K., Yufeng, 唐. T., Songyi, 罗. L., Yang, 白. B., Ping, 李. L., 周良学, & Qihua, 朱. Z. (2026) · Laser & Optoelectronics Progress · doi:10.3788/lop252596
Choi, A., Haystead, A., D’Cunha, R., Hsu, J., Zhu, M., Johnson, K. G., Lutz, M. W., Whitson, H. E., Grewal, D. S., & Fekrat, S. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.10.6
Rosenberg, A., Solomon, A., Matton, A., Lehtisalo, J., Benedet, A. L., Mangialasche, F., Levälahti, E., Arslan, B., Daniilidou, M., Peltonen, M., et al. (2026) · medRxiv · doi:10.64898/2026.10.02.26364486 · Cited by 1
Yuqi, L., & Gu, J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1925934
Yin, G., Tan, W., Wang, D., He, Z., 窦彩霞, Wang, H., Lu, Q., 钟根深, Du, F., & Yin, P. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c05055
Hwang, J., Figueredo, L. F., Valencia, D. I., Tolbert, T. M., Hamada, E., Zhou, L., Gills, J. L., Ruiz, J., Martillo, K., Chu, S. S. H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71910
Zhao, B., Li, M., Yi, L., & Li, J. (2026) · Research Square · doi:10.21203/rs.3.rs-11025635/v1
Self-citationA cross-species AAV platform for precise microglial interrogation
Yu, F., Wang, R., Di, R., Xu, K., Gao, J., Shang, H., Yuan, Z., Dai, R., Wu, W., Weng, D., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.017 · Cited by 1
Zhao, B., Li, M., Yi, L., & Li, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.07.757306
Self-citationSuper-Cross-Reactive Recognition Enables Preclinical Diagnosis of Alzheimer’s Disease
Li, W., Li, J., Ning, X., Tian, J., Chen, F., Zhang, S.-X., Wang, Z.-H., Pan, Y., Zhang, W., & Guo, D. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c14717
Utility of extracellular vesicles in the diagnosis of central nervous system diseases
Wang, M., 杨俊文, Gao, C., Qu, S., Mi, H., Guo, Y., Gui, T., & Gai, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1959745
Zeng, X., Heaton, N., Deek, R. A., Nafash, M. N., Farinas, M. F., Choity, L. T., Balogun, W. G., Shi, R., Bedison, M. A., Lopresti, B. J., et al. (2026) · medRxiv · doi:10.64898/2026.10.19.26365317
Lou, H., Huang, C., Shen, J., & Wang, D. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150606
Schellin, J., Sehner, S., Neumann, M., Petersen, M., Nägele, F. L., Singh, S., Rosand, J., Schumacher, N., Zyriax, B., Twerenbold, R., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70796
Li, J., Wang, Y., Liu, Y., 姬颖华, Lü, P., Yang, W., & Zhang, S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109709
Self-citationTsoran, L., Rom, Y., Taha, A., Shwaiky, Y., Attal, F., Naveh, N., Levy, Y., Adam, M., Fainstein, N., Habib, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.26.761827
Gu, S., Zhang, P., 罗家镏, Chen, S., Lin, Z., Wu, Y., Tang, Z., & Zhang, C. (2026) · Biomedicines · doi:10.3390/biomedicines14112523
Amorim, A. R. J., de Carvalho, J. M. J., Amorim, R. J., MELO, E. M. D., Barra, R. C. B., Matos, G. M., Costa, J. R. S., Ribeiro, A. C. D. M. D., Bastos, J. G. E., Rivera, J. F. C. D. M. B., et al. (2026) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2026v8n11p190-213
Olfactory Function in Preclinical Alzheimer’s Disease: A Multi-Cohort StudyPreprint
Jobin, B., Salman, Y., Bouchoucha, K., Huyghe, L., Quenon, L., Colmant, L., Gérard, T., Malotaux, V., Dricot, L., Dulieu, P., et al. (2026) · medRxiv · doi:10.64898/2026.11.03.26367202
Cardiac and vascular involvement in protein misfolding diseases
Stamatelopoulos, K., Georgiopoulos, G. A., Aimo, A., Aivalioti, E., Bauer, K. C., Tual‐Chalot, S., Kraler, S. C., Bampatsias, D., Nuvolone, M., Abdellatif, M., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01359-8
Kamakshamma, V., M.Shanmugapriya, Arputharaj, B. S., & Mittal, A. (2026) · doi:10.1109/worldsuas70880.2026.11766265
Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China
Pu, M., Wen, Y., Chen, Y., Wang, J., 潘晓黎, Wang, G., Li, X., 王桂红, Zuo, C., Shi, J., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70433
Self-citationThe role of lactate in Alzheimer’s disease: from controversies to therapeutic opportunities
Ashley, C. C., & Macauley, S. L. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00057-6
Yang, S., Pei, Z., Lan, X., Lian, C., Liu, Y., Li, Z., Dang, G., Shi, X., 康慧聪, Jiang, X., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122341
Self-citation
Metadata
- Authors
- Jia, J., Ning, Y., Chen, M., Wang, S., Yang, H., Li, F., Ding, J., Li, Y., Zhao, B., Lyu, J., Yang, S., Yan, X., Wang, Y., Qin, W., Wang, Q., Li, Y., Zhang, J., Liang, F., Liao, Z., & Wang, S.
- Affiliations
- Capital Medical University (CN)
- From the Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital (J.J., Y.N., M.C., Shuheng Wang, H.Y., F. Li, J.D., Yan Li, B.Z., W.Q., Q.W., Ying Li), Beijing Key Laboratory of Geriatric Cognitive Disorders, Clinical Center for Neurodegenerative Disease and Memory Impairment (J.J.), the Center of Alzheimer’s Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders (J.J.), and the Department of Neurology, Beijing Anding Hospital (Y.W.), Capital Medical University, Key Laboratory of Neurodegenerative Diseases, Ministry of Education (J.J.), the Center for Cognitive Disorders, Beijing Geriatric Hospital (J.L.), and the Department of Neurology, Beijing Jishuitan Hospital (X.Y.), Beijing, the Department of Neurology, Daqing Oilfield General Hospital, Daqing (S.Y.), the Department of Neurology, the 960th Hospital of the People’s Liberation Army, Jinan (J.Z.), the Department of Neurology, Baotou Central Hospital, Baotou (F. Liang), the Depa...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-02-22
- Volume
- 390
- Issue
- 8
- Pages
- 712-722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4391990232
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 162 · 2025: 202 · 2024: 91
- FWCI
- 133.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30370494, 30410303095, 30470615)
- Mission Program of Beijing Municipal Administration of Hospitals (SML20150801)
- Beijing Natural Science Foundation (7071004)
- The National Science and Technology Foundation of China (2003CB517102, 2004BA714B06-1, 2006BAI02B01, 2006CB500700, 2011CB504101, 2011ZX09307-001-03)
- Sailing Plan of Beijing Municipal Administration of Hospitals (ZY201301)
- Major project of Beijing Municipal Science and Technology Commission (D111107003111009)
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520017, Z161100000216137, Z201100005520016)
- Key Project of the National Natural Science Foundation of China (81530036, U20A20354)
- National Key Scientific Instrument and Equipment Development Projects of China (31627803)
- National major R&D projects of China-Scientific technological innovation 2030 (2021ZD0201802)
- CHINACANADA Joint Initiative on Alzheimer’s Disease and Related Disorders (81261120571)
- Beijing Scholars Program
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid-beta 42, phosphorylated tau 181, total tau, neurofilament light chain, hippocampal volume, cognitive decline, sporadic Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Follow-Up Studies, Humans, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.